---
figid: PMC5823602__oncotarget-09-8326-g004
figlink: /pmc/articles/PMC5823602/figure/F4/
number: F4
caption: This graph shows that UBASH3B is negatively regulated by ER and Cisplatin
  and could promote breast cancer progression. TP53 mutation may also promote breast
  cancer progression by regulating UBASH3B expression.
pmcid: PMC5823602
papertitle: UBASH3B promotes tamoxifen resistance and could be negatively regulated
  by ESR1.
reftext: Ketao Jin, et al. Oncotarget. 2018 Feb 2;9(9):8326-8333.
pmc_ranked_result_index: '9352'
pathway_score: 0.936999
filename: oncotarget-09-8326-g004.jpg
figtitle: UBASH3B promotes tamoxifen resistance and could be negatively regulated
  by ESR1
year: '2018'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5823602__oncotarget-09-8326-g004.html
  '@type': Dataset
  description: This graph shows that UBASH3B is negatively regulated by ER and Cisplatin
    and could promote breast cancer progression. TP53 mutation may also promote breast
    cancer progression by regulating UBASH3B expression.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - UBASH3B
  - TP53
  - ESR1
  - MUT
  - Cisplatin
genes:
- word: UBASH3B
  symbol: UBASH3B
  source: hgnc_symbol
  hgnc_symbol: UBASH3B
  entrez: '84959'
- word: TP53
  symbol: TP53
  source: hgnc_symbol
  hgnc_symbol: TP53
  entrez: '7157'
- word: ESR1
  symbol: ESR1
  source: hgnc_symbol
  hgnc_symbol: ESR1
  entrez: '2099'
- word: Mut
  symbol: MUT
  source: hgnc_symbol
  hgnc_symbol: MUT
  entrez: '4594'
chemicals:
- word: Cisplatin
  source: MESH
  identifier: D002945
diseases: []
figid_alias: PMC5823602__F4
redirect_from: /figures/PMC5823602__F4
figtype: Figure
---
